Ganglionic blockade with trimethaphan discriminated between sympathetic-dependent and independent hypertension, lowering SBP below 125 mmHg in MSA patients while remaining elevated in PAF patients.
Observational
Does ganglionic blockade with trimethaphan and LF(SBP) measurement discriminate between sympathetic-dependent and independent hypertension?
Ganglionic blockade coupled with LF(SBP) measurements can effectively discriminate between sympathetic-dependent and independent hypertension, aiding in the physiological phenotyping of essential hypertension.
OBJECTIVE: To determine if the contribution of the sympathetic nervous system to blood pressure could be evidenced by low-frequency oscillations of systolic blood pressure (LF(SBP)), reflecting vascular sympathetic modulation, or by the decrease in blood pressure after autonomic blockade. DESIGN: We studied multiple system atrophy (MSA) patients, in whom supine hypertension is maintained by residual sympathetic tone ('positive controls'); pure autonomic failure (PAF) patients, in whom supine hypertension is largely independent of sympathetic tone ('negative controls'); essential hypertensive patients (HTN) and normotensive subjects (NTN). RESULTS: Supine systolic blood pressure (SBP) was 204 +/- 8, 185 +/- 6, 177 +/- 9 and 130 +/- 4 mmHg in MSA, PAF, HTN and NTN, respectively. LF(SBP) was higher in MSA and HTN (5.7 +/- 1.5 and 5.8 +/- 1.4 mmHg(2) compared to NTN and PAF (3.3 +/- 0.5 and 1.1 +/- 0.5 mmHg(2). Trimethaphan 2-4 mg/min induced complete autonomic blockade and lowered SBP below 125 mmHg in all NTN and all but one MSA (to 111 +/- 3 and 97 +/- 9 mmHg). SBP remained elevated in PAF (164 +/- 7 mmHg). Responses in HTN were variable; SBP decreased below 125 mmHg in three and remained elevated in four patients. The decrease in LF(SBP) correlated with the reduction in SBP, with a steeper slope in MSA and HTN compared to NTN (29.0 +/- 5.5, 8.4 +/- 1.6 and 3.6 +/- 1.2 mmHg/mmH (2), respectively). CONCLUSION: Ganglionic blockade, alone or coupled to LF(SBP), discriminated between human models of sympathetic-dependent (MSA) and independent (PAF) hypertension. This approach may aid in assessing the contribution of the sympathetic nervous system in essential hypertension, in which sympathetic dependence is variably expressed.
Diedrich et al. (Wed,) conducted a observational in Hypertension. Trimethaphan vs. Normotensive subjects and pure autonomic failure patients was evaluated on Systolic blood pressure (SBP) response to autonomic blockade. Ganglionic blockade with trimethaphan discriminated between sympathetic-dependent and independent hypertension, lowering SBP below 125 mmHg in MSA patients while remaining elevated in PAF patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: